Clinical Pharmacology Considerations for Antibody-Drug Conjugates Guidance for Industry: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 1, 2024
March 28, 2024
ee3ed09c-6580-489f-bb06-0e93f612d604
Related Documents
Drug-Drug Interaction Assessment for Therapeutic Proteins Guidance for Industry: Guidance for Industry
Guidance DocumentJune 22, 2023Center for Drug Evaluation and Research
Benefit-Risk Assessment for New Drug and Biological Products
Guidance DocumentOctober 17, 2023Center for Drug Evaluation and Research
Population Pharmacokinetics: Guidance for Industry
Guidance DocumentFebruary 3, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox